Progressive Care's PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in China
February 02 2022 - 7:16AM
InvestorsHub NewsWire
Miami, FL -- February 2, 2022 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:
RXMD) (“Progressive Care” or the “Company”), a personalized
healthcare services and technology provider, is pleased to announce
that its PharmcoRx subsidiary’s gained status as one of the 35
approved COVID-19 test vendors in the U.S. for travel to the
People’s Republic of China (“China”), for the Beijing Winter
Olympic Games.
For a complete list of the approved Covid-19 test vendors from
the Chinese Embassy website, please visit: http://www.china-embassy.org/eng/bwos/
Alan Jay Weisberg, Chairman and Chief Executive Officer of
Progressive Care, commented, “With the upcoming start of the
Olympic Games in Beijing, China, we are honored to have been one of
the selected vendors for COVID-19 testing of U.S. travelers bound
for China. We believe our timeliness, accuracy, and service
differentiate us from other Covid-19 test vendors and were the
basis of our selection.”
Progressive Care, Inc.
Progressive Care, Inc. (OTCQB:
RXMD), through its subsidiaries, is a Florida health services
organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
For more information about Progressive Care, please visit the
company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com/
https://twitter.com/ProgressCareUS
PharmCoRx
https://www.pharmcorx.com/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
Forward-Looking Statements:
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company’s
expectations about its future operating results, performance, and
opportunities that involve substantial risks and uncertainties.
When used herein, the words “anticipate,” “believe,” “estimate,”
“upcoming,” “plan,” “target,” “intend” and “expect” and similar
expressions, as they relate to Progressive Care Inc., its
subsidiaries, or its management, are intended to identify such
forward-looking statements. These forward-looking statements are
based on information currently available to the Company and are
subject to a number of risks, uncertainties, and other factors that
could cause the Company’s actual results, performance, prospects,
and opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Investor Relations Contact:
ClearThink Capital
nyc@clearthink.capital
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Sep 2023 to Sep 2024